Cart
sales@molnova.com
PDE IV-IN-1
CAS No. 225100-12-9
PDE IV-IN-1( —— )
Catalog No. M32762 CAS No. 225100-12-9
PDE IV-IN-1 is a potent phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity for the treatment of asthma, chronic obstructive pulmonary disease and other inflammatory diseases, and is a potential compound for the study of depression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 571 | In Stock |
|
| 5MG | 506 | In Stock |
|
| 10MG | 677 | In Stock |
|
| 25MG | 1017 | In Stock |
|
| 50MG | 1330 | In Stock |
|
| 100MG | 1795 | In Stock |
|
| 200MG | 2409 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePDE IV-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPDE IV-IN-1 is a potent phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity for the treatment of asthma, chronic obstructive pulmonary disease and other inflammatory diseases, and is a potential compound for the study of depression.
-
DescriptionPDE IV-IN-1 is an inhibitor of phosphodiesterase IV, used for the research of asthma, COPD or other inflammatory diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number225100-12-9
-
Formula Weight386.88
-
Molecular FormulaC20H23ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N1C=2C(N=C1C)=C(C)N=C(Cl)N2)C3=CC(OC4CCCC4)=C(OC)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof. US 6919455 B2
molnova catalog
related products
-
FCPR03
FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively.
-
ITI214
ITI-214 is a potent, selective, orally active phosphodiesterase 1 (PDE1) inhibitor with Ki of 58 pM.
-
Tovinontrine
Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment.
